STEM CELLS, ISSN 1066-5099, 05/2011, Volume 29, Issue 5, pp. 825 - 835
Age‐related macular degeneration (AMD) is one of the major causes of blindness in aging population that progresses with death of retinal pigment epithelium...
Telomere shortening | Human induced pluripotent stem cells | Ion transport | Membrane potential | Growth arrest | Gene expression | Retinal pigment epithelium | TRANSLOCATION | MOUSE | MACULAR DEGENERATION | GRAFT | INDUCTION | FIBROBLASTS | TRANSPLANTATION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | MOLECULAR SIGNATURE | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENERATION | HEMATOLOGY | Retinal Pigment Epithelium - metabolism | Membrane Potentials - genetics | Humans | Phagocytosis - physiology | Electrophysiology | Immunoblotting | Vascular Endothelial Growth Factor A - metabolism | Phagocytosis - genetics | Membrane Potentials - physiology | Vascular Endothelial Growth Factor A - secretion | Polymerase Chain Reaction | DNA Damage - genetics | Fibroblasts - cytology | Induced Pluripotent Stem Cells - cytology | Ion Transport - physiology | Retinal Pigment Epithelium - cytology | Fibroblasts - metabolism | Ion Transport - genetics | Macular degeneration | Retina | Vascular endothelial growth factor | Stem cells
Telomere shortening | Human induced pluripotent stem cells | Ion transport | Membrane potential | Growth arrest | Gene expression | Retinal pigment epithelium | TRANSLOCATION | MOUSE | MACULAR DEGENERATION | GRAFT | INDUCTION | FIBROBLASTS | TRANSPLANTATION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | MOLECULAR SIGNATURE | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENERATION | HEMATOLOGY | Retinal Pigment Epithelium - metabolism | Membrane Potentials - genetics | Humans | Phagocytosis - physiology | Electrophysiology | Immunoblotting | Vascular Endothelial Growth Factor A - metabolism | Phagocytosis - genetics | Membrane Potentials - physiology | Vascular Endothelial Growth Factor A - secretion | Polymerase Chain Reaction | DNA Damage - genetics | Fibroblasts - cytology | Induced Pluripotent Stem Cells - cytology | Ion Transport - physiology | Retinal Pigment Epithelium - cytology | Fibroblasts - metabolism | Ion Transport - genetics | Macular degeneration | Retina | Vascular endothelial growth factor | Stem cells
Journal Article
STEM CELLS Translational Medicine, ISSN 2157-6564, 03/2016, Volume 5, Issue 3, pp. 392 - 404
Tissue engineering strategies based on implanting cellularized biomaterials are promising therapeutic approaches for the reconstruction of large tissue...
Angiogenesis | Pulp engineering | Dynamic vascular imaging | Hepatocyte growth factor | Hypoxia | Vascular endothelial growth factor | Mesenchymal stem cells | COLLAGEN | VIVO | EXFOLIATED DECIDUOUS TEETH | SIDE POPULATION CELLS | LIMB ISCHEMIA | VEGF | DIFFERENTIATE | CELL & TISSUE ENGINEERING | IN-VITRO | STROMAL CELLS | Hepatocyte Growth Factor - biosynthesis | Mesenchymal Stromal Cells - drug effects | Vascular Endothelial Growth Factor A - biosynthesis | Cell Hypoxia - drug effects | Hepatocyte Growth Factor - secretion | Neovascularization, Physiologic - genetics | Humans | Fibroblast Growth Factor 2 - biosynthesis | Dental Pulp - cytology | Mesenchymal Stromal Cells - metabolism | Fibroblast Growth Factor 2 - administration & dosage | Vascular Endothelial Growth Factor A - secretion | Mesenchymal Stem Cell Transplantation | Tissue Engineering | Cell culture | Fibroblast growth factor | Hydrogels | Mesenchyme | Biomaterials | Vascularization | Penicillin | Tomography | Fibroblasts | Extracellular matrix | Nutrients | Reconstruction | Data analysis | Cytokines | Tissue engineering | Secretion | Teeth | Grants | Progenitor cells | Endothelial cells | Perfusion | Stem cells | Dental pulp | Life Sciences | Bioengineering | Tissue Engineering and Regenerative Medicine
Angiogenesis | Pulp engineering | Dynamic vascular imaging | Hepatocyte growth factor | Hypoxia | Vascular endothelial growth factor | Mesenchymal stem cells | COLLAGEN | VIVO | EXFOLIATED DECIDUOUS TEETH | SIDE POPULATION CELLS | LIMB ISCHEMIA | VEGF | DIFFERENTIATE | CELL & TISSUE ENGINEERING | IN-VITRO | STROMAL CELLS | Hepatocyte Growth Factor - biosynthesis | Mesenchymal Stromal Cells - drug effects | Vascular Endothelial Growth Factor A - biosynthesis | Cell Hypoxia - drug effects | Hepatocyte Growth Factor - secretion | Neovascularization, Physiologic - genetics | Humans | Fibroblast Growth Factor 2 - biosynthesis | Dental Pulp - cytology | Mesenchymal Stromal Cells - metabolism | Fibroblast Growth Factor 2 - administration & dosage | Vascular Endothelial Growth Factor A - secretion | Mesenchymal Stem Cell Transplantation | Tissue Engineering | Cell culture | Fibroblast growth factor | Hydrogels | Mesenchyme | Biomaterials | Vascularization | Penicillin | Tomography | Fibroblasts | Extracellular matrix | Nutrients | Reconstruction | Data analysis | Cytokines | Tissue engineering | Secretion | Teeth | Grants | Progenitor cells | Endothelial cells | Perfusion | Stem cells | Dental pulp | Life Sciences | Bioengineering | Tissue Engineering and Regenerative Medicine
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2012, Volume 130, Issue 3, pp. 532 - 543
The PI3 kinase/Akt pathway is commonly deregulated in human cancers, functioning in such processes as proliferation, glucose metabolism, survival and motility....
B-GAMMA | ONCOLOGY | EBAG9/RCAS1 | NITRIC-OXIDE | INDUCTION | ANTIGEN RCAS1 | HYPOXIA | PHOSPHOINOSITIDE 3-KINASE | EXPRESSION | P42/P44 MAP KINASE | SIGNALING ANGIOGENESIS | Humans | Gene Expression Regulation, Neoplastic | Endoplasmic Reticulum - metabolism | Vascular Endothelial Growth Factor A - metabolism | Proto-Oncogene Proteins c-akt - genetics | Vascular Endothelial Growth Factor A - secretion | Ovarian Neoplasms - genetics | Mitochondria - genetics | Antigens, Neoplasm - metabolism | Biomarkers, Tumor - metabolism | Female | Tumor Burden - genetics | Ovarian Neoplasms - blood supply | Proto-Oncogene Proteins c-akt - metabolism | Signal Transduction | Gene Silencing | PTEN Phosphohydrolase - metabolism | Mitochondria - metabolism | Mice, SCID | Ovarian Neoplasms - enzymology | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Mice | Kinases | Gene expression | Vascular endothelial growth factor | Ovarian cancer
B-GAMMA | ONCOLOGY | EBAG9/RCAS1 | NITRIC-OXIDE | INDUCTION | ANTIGEN RCAS1 | HYPOXIA | PHOSPHOINOSITIDE 3-KINASE | EXPRESSION | P42/P44 MAP KINASE | SIGNALING ANGIOGENESIS | Humans | Gene Expression Regulation, Neoplastic | Endoplasmic Reticulum - metabolism | Vascular Endothelial Growth Factor A - metabolism | Proto-Oncogene Proteins c-akt - genetics | Vascular Endothelial Growth Factor A - secretion | Ovarian Neoplasms - genetics | Mitochondria - genetics | Antigens, Neoplasm - metabolism | Biomarkers, Tumor - metabolism | Female | Tumor Burden - genetics | Ovarian Neoplasms - blood supply | Proto-Oncogene Proteins c-akt - metabolism | Signal Transduction | Gene Silencing | PTEN Phosphohydrolase - metabolism | Mitochondria - metabolism | Mice, SCID | Ovarian Neoplasms - enzymology | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Mice | Kinases | Gene expression | Vascular endothelial growth factor | Ovarian cancer
Journal Article
Journal of Biomedical Materials Research Part A, ISSN 1549-3296, 07/2014, Volume 102, Issue 7, pp. 2096 - 2104
Porous β‐CaSiO3/β‐Ca3(PO4)2 (β‐CS/β‐TCP) composite scaffolds have been previously shown to promote bone formation in vivo. However, the mechanisms underlying...
bioactive ions | AMPK | calcium silicate | tricalcium phosphate | osteogenic differentiation | Endothelium, Vascular - cytology | Human Umbilical Vein Endothelial Cells | Calcium Compounds | Humans | Rats | Silicates | DNA Primers | Rats, Sprague-Dawley | Vascular Endothelial Growth Factor A - secretion | Tissue Scaffolds | Calcium Phosphates | Animals | Endothelium, Vascular - secretion | Adenylate Kinase - metabolism | Base Sequence | Cell Differentiation | Real-Time Polymerase Chain Reaction | Bone and Bones - cytology
bioactive ions | AMPK | calcium silicate | tricalcium phosphate | osteogenic differentiation | Endothelium, Vascular - cytology | Human Umbilical Vein Endothelial Cells | Calcium Compounds | Humans | Rats | Silicates | DNA Primers | Rats, Sprague-Dawley | Vascular Endothelial Growth Factor A - secretion | Tissue Scaffolds | Calcium Phosphates | Animals | Endothelium, Vascular - secretion | Adenylate Kinase - metabolism | Base Sequence | Cell Differentiation | Real-Time Polymerase Chain Reaction | Bone and Bones - cytology
Journal Article
Journal of Vascular Research, ISSN 1018-1172, 05/2017, Volume 54, Issue 2, pp. 100 - 108
Adult stem cells have been studied as a promising therapeutic modality for the functional restoration of the damaged heart. In the present study, a strategy...
Neurofibromin 2 | Vascular endothelial growth factor secretion | Angiogenesis | Micro-RNA-146a | PHYSIOLOGY | PROTEIN | VEGF | REGENERATION | TUMOR-SUPPRESSOR GENE | MICRORNAS | CANCER | SIGNALING PATHWAY | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | NEUROFIBROMATOSIS TYPE-2 | Myocardial Infarction - genetics | Up-Regulation | Neurofibromin 2 - genetics | Humans | rac GTP-Binding Proteins - metabolism | Male | MicroRNAs - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Recovery of Function | Myocardial Reperfusion Injury - surgery | Vascular Endothelial Growth Factor A - secretion | Myocardial Reperfusion Injury - pathology | Transfection | Myocardial Infarction - pathology | Myocardium - metabolism | 3' Untranslated Regions | Binding Sites | Myocardial Reperfusion Injury - genetics | Neurofibromin 2 - metabolism | Disease Models, Animal | Myocardial Infarction - surgery | Signal Transduction | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Myocardium - pathology | Mesenchymal Stromal Cells - secretion | Myocardial Infarction - metabolism | p21-Activated Kinases - metabolism | Rats, Sprague-Dawley | Myocardial Reperfusion Injury - metabolism | Regeneration | Animals | Fibrosis | MicroRNAs - genetics | Mesenchymal Stem Cell Transplantation | Neovascularization, Physiologic
Neurofibromin 2 | Vascular endothelial growth factor secretion | Angiogenesis | Micro-RNA-146a | PHYSIOLOGY | PROTEIN | VEGF | REGENERATION | TUMOR-SUPPRESSOR GENE | MICRORNAS | CANCER | SIGNALING PATHWAY | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | NEUROFIBROMATOSIS TYPE-2 | Myocardial Infarction - genetics | Up-Regulation | Neurofibromin 2 - genetics | Humans | rac GTP-Binding Proteins - metabolism | Male | MicroRNAs - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Recovery of Function | Myocardial Reperfusion Injury - surgery | Vascular Endothelial Growth Factor A - secretion | Myocardial Reperfusion Injury - pathology | Transfection | Myocardial Infarction - pathology | Myocardium - metabolism | 3' Untranslated Regions | Binding Sites | Myocardial Reperfusion Injury - genetics | Neurofibromin 2 - metabolism | Disease Models, Animal | Myocardial Infarction - surgery | Signal Transduction | Cells, Cultured | Mesenchymal Stromal Cells - metabolism | Myocardium - pathology | Mesenchymal Stromal Cells - secretion | Myocardial Infarction - metabolism | p21-Activated Kinases - metabolism | Rats, Sprague-Dawley | Myocardial Reperfusion Injury - metabolism | Regeneration | Animals | Fibrosis | MicroRNAs - genetics | Mesenchymal Stem Cell Transplantation | Neovascularization, Physiologic
Journal Article
Journal of Endocrinology, ISSN 0022-0795, 02/2008, Volume 196, Issue 2, pp. 399 - 412
Environmental chemicals may affect human health by disrupting endocrine function. Their possible role in the mammary gland and breast tumors is still unknown....
MENSTRUAL-CYCLE | FACTOR VEGF | ENDOCRINE DISRUPTORS | PERMEABILITY FACTOR EXPRESSION | IN-UTERO EXPOSURE | ENDOCRINOLOGY & METABOLISM | BISPHENOL-A ALTERS | GENE-EXPRESSION | MAMMARY-CANCER | ENVIRONMENTAL ESTROGENS | ORGANOCHLORINE PESTICIDES | Phosphotransferases - metabolism | Cell Survival - drug effects | Up-Regulation | Estrogens - pharmacology | Humans | Breast Neoplasms - physiopathology | Xenobiotics - pharmacology | Breast Neoplasms - metabolism | Vascular Endothelial Growth Factor A - secretion | Breast Neoplasms - pathology | Genistein - pharmacology | Estrogen Receptor alpha - metabolism | Female | Phytoestrogens - pharmacology
MENSTRUAL-CYCLE | FACTOR VEGF | ENDOCRINE DISRUPTORS | PERMEABILITY FACTOR EXPRESSION | IN-UTERO EXPOSURE | ENDOCRINOLOGY & METABOLISM | BISPHENOL-A ALTERS | GENE-EXPRESSION | MAMMARY-CANCER | ENVIRONMENTAL ESTROGENS | ORGANOCHLORINE PESTICIDES | Phosphotransferases - metabolism | Cell Survival - drug effects | Up-Regulation | Estrogens - pharmacology | Humans | Breast Neoplasms - physiopathology | Xenobiotics - pharmacology | Breast Neoplasms - metabolism | Vascular Endothelial Growth Factor A - secretion | Breast Neoplasms - pathology | Genistein - pharmacology | Estrogen Receptor alpha - metabolism | Female | Phytoestrogens - pharmacology
Journal Article
Reproductive BioMedicine Online, ISSN 1472-6483, 2017, Volume 34, Issue 4, pp. 406 - 413
Abstract Pre-eclampsia, characterized as defective uteroplacental vascularization, remains the major cause of maternal and fetal mortality and morbidity....
Obstetrics and Gynecology | pre-eclampsia | trophoblast cells | VEGF | Nicotine | RISK | PREECLAMPSIA | CANCER | PREGNANCY | OBSTETRICS & GYNECOLOGY | CIGARETTE-SMOKING | REPRODUCTIVE BIOLOGY | LETHALITY | GENE | ENDOMETRIAL | EXPRESSION | Human Umbilical Vein Endothelial Cells | Vascular Endothelial Growth Factor A - biosynthesis | Vascular Endothelial Growth Factor Receptor-1 - secretion | Cell Proliferation | Trophoblasts - metabolism | Humans | Cells, Cultured | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Nicotine - pharmacology | Vascular Endothelial Growth Factor A - secretion | Cell Hypoxia | Trophoblasts - drug effects | Female | Trophoblasts - cytology
Obstetrics and Gynecology | pre-eclampsia | trophoblast cells | VEGF | Nicotine | RISK | PREECLAMPSIA | CANCER | PREGNANCY | OBSTETRICS & GYNECOLOGY | CIGARETTE-SMOKING | REPRODUCTIVE BIOLOGY | LETHALITY | GENE | ENDOMETRIAL | EXPRESSION | Human Umbilical Vein Endothelial Cells | Vascular Endothelial Growth Factor A - biosynthesis | Vascular Endothelial Growth Factor Receptor-1 - secretion | Cell Proliferation | Trophoblasts - metabolism | Humans | Cells, Cultured | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Nicotine - pharmacology | Vascular Endothelial Growth Factor A - secretion | Cell Hypoxia | Trophoblasts - drug effects | Female | Trophoblasts - cytology
Journal Article
Tissue Engineering Part A, ISSN 1937-3341, 09/2012, Volume 18, Issue 17-18, pp. 1771 - 1783
We previously showed that the sequential, but not simultaneous, culture of endothelial cells (ECs), fibroblasts (FBs), and cardiomyocytes (CMs) resulted in...
Original Articles | CELLS | ACTIVATED PROTEIN-KINASE | STIMULATION | MYOCYTES | ANGIOGENESIS | VEGF | MUSCLE | CYCLICAL MECHANICAL STRETCH | FIBROBLASTS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENE-EXPRESSION | Cell Count | Myocardial Contraction - drug effects | Protein Transport - drug effects | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - secretion | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Myocardium - metabolism | Organoids - metabolism | Cell Death - drug effects | Vascular Endothelial Growth Factor A - pharmacology | Connexin 43 - genetics | Fibroblasts - metabolism | Animals, Newborn | Connexin 43 - metabolism | Myocytes, Cardiac - cytology | Endothelial Cells - metabolism | RNA, Messenger - genetics | Cells, Cultured | Rats | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Antibodies, Neutralizing - pharmacology | Up-Regulation - genetics | Down-Regulation - drug effects | Down-Regulation - genetics | Up-Regulation - drug effects | Animals | Myocytes, Cardiac - drug effects | Endothelial Cells - cytology | Fibroblasts - drug effects | Organoids - drug effects | Myocytes, Cardiac - metabolism | Ligands | Fibroblasts - cytology | Electrophysiological Phenomena - drug effects | Endothelial Cells - drug effects | Heart | Cell culture | Cardiology | Tissue engineering | Vascular endothelial growth factor | Indexing in process | Original
Original Articles | CELLS | ACTIVATED PROTEIN-KINASE | STIMULATION | MYOCYTES | ANGIOGENESIS | VEGF | MUSCLE | CYCLICAL MECHANICAL STRETCH | FIBROBLASTS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENE-EXPRESSION | Cell Count | Myocardial Contraction - drug effects | Protein Transport - drug effects | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - secretion | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Myocardium - metabolism | Organoids - metabolism | Cell Death - drug effects | Vascular Endothelial Growth Factor A - pharmacology | Connexin 43 - genetics | Fibroblasts - metabolism | Animals, Newborn | Connexin 43 - metabolism | Myocytes, Cardiac - cytology | Endothelial Cells - metabolism | RNA, Messenger - genetics | Cells, Cultured | Rats | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Antibodies, Neutralizing - pharmacology | Up-Regulation - genetics | Down-Regulation - drug effects | Down-Regulation - genetics | Up-Regulation - drug effects | Animals | Myocytes, Cardiac - drug effects | Endothelial Cells - cytology | Fibroblasts - drug effects | Organoids - drug effects | Myocytes, Cardiac - metabolism | Ligands | Fibroblasts - cytology | Electrophysiological Phenomena - drug effects | Endothelial Cells - drug effects | Heart | Cell culture | Cardiology | Tissue engineering | Vascular endothelial growth factor | Indexing in process | Original
Journal Article
9.
Full Text
Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence
Journal of Biological Chemistry, ISSN 0021-9258, 10/2006, Volume 281, Issue 40, pp. 29568 - 29574
Cellular senescence prevents the proliferation of cells at risk for neoplastic transformation. Nonetheless, the senescence response is thought to be...
ANGIOGENESIS | HUMAN-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | TUMOR-SUPPRESSOR | STROMAL FIBROBLASTS | REPLICATIVE LIFE-SPAN | CELLULAR SENESCENCE | CANCER | EXPRESSION | P53 | Vascular Endothelial Growth Factor A - biosynthesis | Fibroblasts - secretion | Humans | Cells, Cultured | Cellular Senescence - physiology | Cell Transformation, Neoplastic - metabolism | Neovascularization, Pathologic - etiology | Vascular Endothelial Growth Factor A - secretion | Culture Media, Conditioned | Animals | Mice, Nude | Neoplasm Invasiveness - pathology | Mammary Neoplasms, Experimental - pathology | Cell Line, Tumor | Adult | Mammary Neoplasms, Experimental - blood supply | Mice | Neovascularization, Pathologic - metabolism | Cell Transformation, Neoplastic - pathology | Mammary Neoplasms, Experimental - etiology
ANGIOGENESIS | HUMAN-CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | TUMOR-SUPPRESSOR | STROMAL FIBROBLASTS | REPLICATIVE LIFE-SPAN | CELLULAR SENESCENCE | CANCER | EXPRESSION | P53 | Vascular Endothelial Growth Factor A - biosynthesis | Fibroblasts - secretion | Humans | Cells, Cultured | Cellular Senescence - physiology | Cell Transformation, Neoplastic - metabolism | Neovascularization, Pathologic - etiology | Vascular Endothelial Growth Factor A - secretion | Culture Media, Conditioned | Animals | Mice, Nude | Neoplasm Invasiveness - pathology | Mammary Neoplasms, Experimental - pathology | Cell Line, Tumor | Adult | Mammary Neoplasms, Experimental - blood supply | Mice | Neovascularization, Pathologic - metabolism | Cell Transformation, Neoplastic - pathology | Mammary Neoplasms, Experimental - etiology
Journal Article
Pituitary, ISSN 1386-341X, 3/2013, Volume 16, Issue 1, pp. 91 - 100
Dopamine (DA) therapy of non-functioning pituitary adenomas (NFA) can result in tumor stabilization and shrinkage. However, the mechanism of action is still...
Diabetes | Medicine & Public Health | Human Physiology | Non functioning pituitary adenomas | Dopamine receptor type 2 | Vascular endothelial growth factor | FACTOR-A | BROMOCRIPTINE | TUMOR CELLS | MACROADENOMAS | AGONISTS | RAT PITUITARY | THERAPY | ENDOCRINOLOGY & METABOLISM | ESTROGEN | DOPAMINE-RECEPTORS | EXPRESSION | Cell Survival - drug effects | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - secretion | Pituitary Neoplasms - secretion | Female | Aged | Tumor Cells, Cultured | Receptors, Dopamine - genetics | Vascular Endothelial Growth Factor A - pharmacology | Ergolines - pharmacology | Microscopy, Fluorescence | Cell proliferation | Cell culture | Dopamine | Secretion | Brain tumors | Data processing | Adenoma | Atrophy | Pituitary | Dopamine receptors | Tumors | sulpiride
Diabetes | Medicine & Public Health | Human Physiology | Non functioning pituitary adenomas | Dopamine receptor type 2 | Vascular endothelial growth factor | FACTOR-A | BROMOCRIPTINE | TUMOR CELLS | MACROADENOMAS | AGONISTS | RAT PITUITARY | THERAPY | ENDOCRINOLOGY & METABOLISM | ESTROGEN | DOPAMINE-RECEPTORS | EXPRESSION | Cell Survival - drug effects | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - secretion | Pituitary Neoplasms - secretion | Female | Aged | Tumor Cells, Cultured | Receptors, Dopamine - genetics | Vascular Endothelial Growth Factor A - pharmacology | Ergolines - pharmacology | Microscopy, Fluorescence | Cell proliferation | Cell culture | Dopamine | Secretion | Brain tumors | Data processing | Adenoma | Atrophy | Pituitary | Dopamine receptors | Tumors | sulpiride
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2014, Volume 102, Issue 5, pp. 1468 - 1476.e1
Objective To explore whether a dopamine receptor 2 agonist (D2-ag) can prevent ovarian hyperstimulation syndrome (OHSS) in a rat model by decreasing ovarian...
Internal Medicine | Obstetrics and Gynecology | OHSS | animal model | VEGF | dopamine receptor 2 agonists | Dopamine receptor 2 agonists | Animal model | FACTOR VEGF | CELLS | PHOSPHORYLATION | HYPERPROLACTINEMIA | RATS | HUMAN GRANULOSA | OBSTETRICS & GYNECOLOGY | ASSISTED REPRODUCTION | REPRODUCTIVE BIOLOGY | CAPILLARY-PERMEABILITY | CABERGOLINE | EXPRESSION | Rats, Wistar | Humans | Rats | Treatment Outcome | Ovarian Hyperstimulation Syndrome - metabolism | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Vascular Endothelial Growth Factor A - secretion | Animals | Female | Ovary - drug effects | Ovarian Hyperstimulation Syndrome - drug therapy | Disease Models, Animal | Ovary - metabolism | Physiological aspects | Phenols | Dopamine | Vascular endothelial growth factor | Analysis | Cells
Internal Medicine | Obstetrics and Gynecology | OHSS | animal model | VEGF | dopamine receptor 2 agonists | Dopamine receptor 2 agonists | Animal model | FACTOR VEGF | CELLS | PHOSPHORYLATION | HYPERPROLACTINEMIA | RATS | HUMAN GRANULOSA | OBSTETRICS & GYNECOLOGY | ASSISTED REPRODUCTION | REPRODUCTIVE BIOLOGY | CAPILLARY-PERMEABILITY | CABERGOLINE | EXPRESSION | Rats, Wistar | Humans | Rats | Treatment Outcome | Ovarian Hyperstimulation Syndrome - metabolism | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Vascular Endothelial Growth Factor A - secretion | Animals | Female | Ovary - drug effects | Ovarian Hyperstimulation Syndrome - drug therapy | Disease Models, Animal | Ovary - metabolism | Physiological aspects | Phenols | Dopamine | Vascular endothelial growth factor | Analysis | Cells
Journal Article
International Journal of Oncology, ISSN 1019-6439, 06/2013, Volume 42, Issue 6, pp. 1919 - 1928
Prostate cancer is the second leading cause of male-cancer related death in the United States. Despite a number of evidence-based studies which strongly...
Prostate cancer | Vascular endothelial growth factor | Nuclear heme oxygenase 1 | Cigarette smoke | APOPTOSIS | nuclear heme oxygenase 1 | ANGIOGENESIS | VEGF | INDUCTION | cigarette smoke | ZINC PROTOPORPHYRIN | prostate cancer | INHIBITION | ONCOLOGY | vascular endothelial growth factor | NITRIC-OXIDE | HYDROGEN-PEROXIDE | TUMOR-GROWTH | EXPRESSION | Smoking - adverse effects | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Heme Oxygenase-1 - metabolism | Humans | Molecular Sequence Data | Male | Protein Transport - drug effects | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor A - secretion | Heme Oxygenase-1 - genetics | Cell Nucleus - metabolism | Prostatic Neoplasms - genetics | Base Sequence | HEK293 Cells | Cell Line, Tumor | Cell Nucleus - drug effects | Prostatic Neoplasms - chemically induced
Prostate cancer | Vascular endothelial growth factor | Nuclear heme oxygenase 1 | Cigarette smoke | APOPTOSIS | nuclear heme oxygenase 1 | ANGIOGENESIS | VEGF | INDUCTION | cigarette smoke | ZINC PROTOPORPHYRIN | prostate cancer | INHIBITION | ONCOLOGY | vascular endothelial growth factor | NITRIC-OXIDE | HYDROGEN-PEROXIDE | TUMOR-GROWTH | EXPRESSION | Smoking - adverse effects | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Heme Oxygenase-1 - metabolism | Humans | Molecular Sequence Data | Male | Protein Transport - drug effects | Vascular Endothelial Growth Factor A - genetics | Vascular Endothelial Growth Factor A - secretion | Heme Oxygenase-1 - genetics | Cell Nucleus - metabolism | Prostatic Neoplasms - genetics | Base Sequence | HEK293 Cells | Cell Line, Tumor | Cell Nucleus - drug effects | Prostatic Neoplasms - chemically induced
Journal Article
Tissue Engineering Part A, ISSN 1937-3341, 11/2013, Volume 19, Issue 21-22, pp. 233 - 2338
Adipose-derived stem cells (ADSCs) possess potent angiogenic properties and represent a source for cell-based approaches to delivery of bioactive factors to...
Original Articles | ACTIVATION | SPHEROIDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MECHANISMS | FIBROBLASTS | PROGRESSION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cell Hypoxia - physiology | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Humans | Cells, Cultured | Adipocytes - cytology | Stem Cells - cytology | Cell Hypoxia - genetics | Stem Cells - metabolism | Cell Survival - physiology | Vascular Endothelial Growth Factor A - secretion | Cell culture | Angiogenesis | Body fat | Tissue engineering | Vascular endothelial growth factor | Stem cells | Original
Original Articles | ACTIVATION | SPHEROIDS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MECHANISMS | FIBROBLASTS | PROGRESSION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cell Hypoxia - physiology | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Humans | Cells, Cultured | Adipocytes - cytology | Stem Cells - cytology | Cell Hypoxia - genetics | Stem Cells - metabolism | Cell Survival - physiology | Vascular Endothelial Growth Factor A - secretion | Cell culture | Angiogenesis | Body fat | Tissue engineering | Vascular endothelial growth factor | Stem cells | Original
Journal Article